https://www.europesays.com/ch/149002/ Novartis remibrutinib delivered comprehensive disease #MediaRelease #MedicalInnovations #Neuroscience #Novartis #NovartisPharmaAG #ReimagineMedicine #ScientificDiscoveries #SwissStockExchange:NOVNSW
#swissstockexchange — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #swissstockexchange, aggregated by home.social.
-
Novartis receives European Commission approval for
Cosentyx® (secukinumab) becomes first and only IL-17A inhibitor approved in Europe for adults with PMR,1 a common inflammatory…
#Europe #EU #EuropeanCommission #ChronicIllness #innovation #mediarelease #NovartisPharmaAG #ReimagineMedicine #SwissStockExchange:NOVN.SW
https://www.europesays.com/europe/164077/ -
https://www.europesays.com/ch/147619/ Novartis receives European Commission approval for #ChronicIllness #Innovation #MediaRelease #Novartis #NovartisPharmaAG #ReimagineMedicine #SwissStockExchange:NOVNSW